ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Biora Therapeutics Inc

Biora Therapeutics Inc (BIOR)

0.6501
-0.0174
(-2.61%)
Closed September 14 4:00PM
0.68
0.0299
(4.60%)
After Hours: 7:47PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.68
Bid
0.641
Ask
0.67
Volume
276,825
0.6375 Day's Range 0.68
0.475 52 Week Range 28.75
Market Cap
Previous Close
0.6675
Open
0.6656
Last Trade
8
@
0.643046
Last Trade Time
Financial Volume
$ 179,323
VWAP
0.647785
Average Volume (3m)
282,990
Shares Outstanding
36,469,088
Dividend Yield
-
PE Ratio
-0.19
Earnings Per Share (EPS)
-3.4
Revenue
4k
Net Profit
-124.12M

About Biora Therapeutics Inc

Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Dover, Delaware, USA
Founded
-
Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $0.67. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 0.475 to $ 28.75.

Biora Therapeutics currently has 36,469,088 shares outstanding. The market capitalization of Biora Therapeutics is $24.34 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.19.

BIOR Latest News

Biora Therapeutics Achieves ISO 13485 Certification

SAN DIEGO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it has been awarded ISO 13485:2016...

Biora Therapeutics Announces Positive Nasdaq Listing Decision

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that the company has been granted an...

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00630.9351343327890.67370.710.631295150.67342424CS
4-0.02-2.857142857140.70.790.5551941610.66528416CS
12-0.5-42.37288135591.181.330.4752829900.72538837CS
26-2.12-75.71428571432.82.850.4753688561.11840609CS
52-20.82-96.837209302321.528.750.4759215219.90567271CS
156-20.82-96.837209302321.528.750.4759215219.90567271CS
2600000.68000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
205.22k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
50.1M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.87M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.91M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.24M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
30.45M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
34.54M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
5.06M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
225.83M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
168.56M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
131.85M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
122.46M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
119.52M

BIOR Discussion

View Posts
The Night Stalker The Night Stalker 4 months ago
nice
👍️0
Arnold25764 Arnold25764 4 months ago
Any possible catalyst here?
👍️0
Monksdream Monksdream 5 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 5 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 6 months ago
BIOR 10Q due 3/26
👍️0
Monksdream Monksdream 6 months ago
BIOR under $2
👍️0
glenn1919 glenn1919 6 months ago
BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 months ago
BIOR new 52 week low
👍️0
Monksdream Monksdream 9 months ago
BOIR new 52 week low
👍️0
Monksdream Monksdream 9 months ago
BIOR new 52 week low
👍️0
TheFinalCD TheFinalCD 9 months ago
https://finviz.com/quote.ashx?t=BIOR&p=d

https://dilutiontracker.com/app/search/BIOR
👍️0
Awl416 Awl416 9 months ago
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
👍️0
retireat40 retireat40 11 months ago
Looked good this morning at 2.66 but a crappy close.
👍️0
Monksdream Monksdream 1 year ago
BIOR Barchart Bottom 100
Biora Therapeutics Inc NASDAQ: BIOR



GoSymbol lookup
Health Care : Biotechnology | Small Cap ValueCompany profile
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
👍️0

Your Recent History

Delayed Upgrade Clock